Quarterly report pursuant to Section 13 or 15(d)

7. SEGMENTS (Tables)

v3.5.0.2
7. SEGMENTS (Tables)
 9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
SEGMENTS

    Plasma                    
Three Months Ended   Collection     Research and              
September 30, 2016   Centers     Development     Corporate     Consolidated  
                         
Revenues   $ 2,902,155     $ -     $ 35,708     $ 2,937,863  
Cost of product revenue     1,735,771       -       -       1,735,771  
Gross profit     1,166,384       -       35,708       1,202,092  
Loss from operations     (316,202 )     (1,677,263 )     (1,743,407 )     (3,736,872 )
Other expense, net     -       -       (594,367 )     (594,367 )
Net loss     (316,202 )     (1,677,263 )     (2,337,774 )     (4,331,239 )
Total assets     2,707,636       -       24,787,750       27,495,386  
Depreciation and                                
amortization expense     103,493       -       13,815       117,308  

 

    Plasma                    
Three Months Ended   Collection     Research and              
September 30, 2015   Centers     Development     Corporate     Consolidated  
                         
Revenues   $ 1,821,229     $ -     $ 31,184     $ 1,852,413  
Cost of product revenue     1,112,782       -       -       1,112,782  
Gross profit     708,447       -       31,184       739,631  
Loss from operations     (505,711 )     (2,111,505 )     (2,046,982 )     (4,664,198 )
Other expense, net     -       -       (438,226 )     (438,226 )
Net loss     (505,711 )     (2,111,505 )     (2,485,208 )     (5,102,424 )
Total assets     3,074,076       -       24,749,954       27,824,030  
Depreciation and                                
amortization expense     105,192       -       12,738       117,930  

  

    Plasma                    
Nine Months Ended   Collection     Research and              
September 30, 2016   Centers     Development     Corporate     Consolidated  
                         
Revenues   $ 7,226,368     $ -     $ 107,125     $ 7,333,493  
Cost of product revenue     4,346,433       -       -       4,346,433  
Gross profit     2,879,935       -       107,125       2,987,060  
Loss from operations     (1,177,371 )     (7,104,864 )     (5,104,023 )     (13,386,258 )
Other expense, net     -       -       (1,569,785 )     (1,569,785 )
Net loss     (1,177,371 )     (7,104,864 )     (6,673,808 )     (14,956,043 )
Total assets     2,707,636       -       24,787,750       27,495,386  
Depreciation and                                
amortization expense     311,012       -       40,690       351,702  

 

    Plasma                    
Nine Months Ended   Collection     Research and              
September 30, 2015   Centers     Development     Corporate     Consolidated  
                         
Revenues   $ 4,596,490     $ -     $ 68,962     $ 4,665,452  
Cost of product revenue     2,808,726       -       -       2,808,726  
Gross profit     1,787,764       -       68,962       1,856,726  
Loss from operations     (1,571,366 )     (5,019,138 )     (4,792,636 )     (11,383,140 )
Other expense, net     -       -       (2,004,137 )     (2,004,137 )
Net loss     (1,571,366 )     (5,019,138 )     (6,796,773 )     (13,387,277 )
Total assets     3,074,076       -       24,749,954       27,824,030  
Depreciation and                                
amortization expense     315,209       -       37,420       352,629